New transaction for Laboratoire XO

,
Paris, October 29, 2021 - Laboratoire X.O has entered into a transaction with Astellas Pharma Inc. for the rights to nicardipine (3 brands) in 4 European countries. This will strengthen our portfolio of 24 brands and our European footprint. Since…

Laboratoire XO celebrates its 5th anniversary

,
Laboratoire X.O is a French success story. Our objective? To provide patients and healthcare professionals with innovative, qualitative products of real therapeutic interest. The story began in 2015 with the acquisition of 2 brands identified…

Laboratoire XO launches its brand new mouthwash

,
As part of the extension of Laboratoire X.O's range of OTC products, a new range of cosmetic mouthwashes with disruptive flavours has been launched: Prexifresh Mango & Mint. This is a daily treatment whose objective is to reduce the…

1 in 2 women suffer from painful periods…

,
1 femme sur 2 souffre de règles douloureuses... According to a study carried out on a representative sample of patients from the Social Security Health Examination Centres, 49% of non-menopausal women suffer from pain during their periods. Dysmenorrhoea…